Medroxyprogesterone And Medroxyprogesterone Acetate

Role

Indications

Reactions

Primary

Hormone Replacement Therapy	72.6%
Menopause	6.0%
Hypertension	5.3%
Menopausal Symptoms	5.3%
Anxiety	1.1%
Depression	1.1%
Menorrhagia	1.1%
Thyroid Disorder	1.1%
Blood Cholesterol Increased	0.8%
Blood Pressure	0.8%
Cardiac Disorder	0.8%
Contraception	0.8%
Osteoporosis	0.8%
Arthritis	0.4%
Atrial Flutter	0.4%
Breast Cancer	0.4%
Breast Cancer Metastatic	0.4%
Headache	0.4%
Hypothyroidism	0.4%
Myocardial Infarction	0.4%

Breast Cancer Female	47.2%
Breast Cancer	22.2%
Coeliac Disease	2.8%
Nausea	2.8%
Ovarian Cancer	2.8%
Progesterone Receptor Assay Positive	2.8%
Cerebral Infarction	1.4%
Diabetes Insipidus	1.4%
Endometrial Cancer	1.4%
Haemorrhage	1.4%
Insulin Resistance	1.4%
Myocardial Infarction	1.4%
Osteoporosis	1.4%
Pneumonia	1.4%
Psychotic Disorder	1.4%
Surgery	1.4%
Transverse Sinus Thrombosis	1.4%
Unintended Pregnancy	1.4%
Urinary Tract Infection	1.4%
Uterine Leiomyoma	1.4%

Secondary

Hormone Replacement Therapy	74.3%
Menopausal Symptoms	8.4%
Menopause	6.3%
Hypertension	2.6%
Blood Cholesterol Increased	0.8%
Anxiety	0.7%
Depression	0.7%
Thyroid Disorder	0.7%
Hot Flush	0.7%
Blood Pressure	0.6%
Diabetes Mellitus	0.5%
Hypothyroidism	0.5%
Blood Cholesterol	0.5%
Arthritis	0.5%
Asthma	0.5%
Cardiac Disorder	0.4%
Gastrooesophageal Reflux Disease	0.4%
Hypersensitivity	0.4%
Osteoporosis	0.4%
Migraine	0.3%

Breast Cancer Female	65.3%
Breast Cancer	25.4%
Ovarian Cancer	2.5%
Breast Cancer In Situ	1.2%
Progesterone Receptor Assay Positive	0.9%
Breast Cancer Metastatic	0.6%
Myocardial Infarction	0.6%
Cerebrovascular Accident	0.4%
Thrombosis	0.4%
Uterine Cancer	0.4%
Deep Vein Thrombosis	0.3%
Insomnia	0.3%
Gallbladder Cancer	0.2%
Metastases To Bone	0.2%
Neuropathy Peripheral	0.2%
Optic Ischaemic Neuropathy	0.2%
Transient Ischaemic Attack	0.2%
Urinary Tract Infection	0.2%
Breast Cancer Recurrent	0.1%
Breast Hyperplasia	0.1%